Duke University is known as one of the largest research institutions in the nation after ranking 3rd in life science R&D last year and spending over $850M on it’s numerous projects.Read More
Biotechnology Calendar, Inc. would like to offer lab suppliers an opportunity to present their lab products at a market that was ranked 2nd in the nation by the NSF for life science funding in 2014.Read More
Does $811,296,000 sound good to your lab supply company?Read More
Duke University, in the picturesque town of Durham, North Carolina, is a well-funded research institution that produces high amounts of life science research and publishes numerous influential articles each year. With millions of dollars of annual funding awarded to the institution to support ongoing research and help fund new projects, the Duke University research marketplace is continuously growing and expanding.Read More
North Carolina is a profitable market for lab suppliers working to meet researchers and sell lab equipment in the Southeast, and Biotechnology Calendar, Inc. life science events in North Carolina are the perfect opportunity to get the word out on your lab products and services at Duke University. Our Duke BioResearch Product Faire™ Event will be held on May 8th, 2014. This popular event attracts hundreds of attendees with a wealth of research funding available to fund their day-to-day lab needs.
Lab suppliers interested in marketing their life science products and working to sell lab equipment in North Carolina may want to take note of Biotechnology Calendar, Inc.’s University of North Carolina at Chapel Hill life science events. Our Chapel Hill BioResearch Product Faire™ Event will take place on May 7th, 2014. In 2012, the Chapel Hill BioResearch Product Faire™ Event attracted 87 attendees. Of those who attended, 37 were purchasing agents, professors and post docs, and 15 were lab managers. The attendees came from 14 different research buildings and 25 departments across campus.
The University of North Carolina at Chapel Hill’s Lineberger Comprehensive Cancer Center recently received $6.7 million from the NIH this year. On the NIH website, the project leader is listed as Henry Shelton Earp, MD, a professor in the Department of Medicine and the Director of the Lineberger Comprehensive Cancer Center. According to the UNC Chapel Hill webpage, Dr. Earp’s lab is focused on how signals from membrane receptors are transduced to nucleus altering cell shape, proliferation, differentiation and gene expression. The NIH RePORTER provides more information on the Lineberger Comprehensive Cancer Center in Dr. Earp’s funding request abstract:
A great deal of life science funding was awarded to Duke University on June 14th, 2013 when the NIH gave researchers $13.8 million to study the induction of protective B-cell responses to HIV-1. The study’s project leader, Barton Haynes, is Director of the Human Vaccine Institute in the Department of Medicine. According to the Duke University website, Dr. Haynes’s laboratory is interested in researching host innate and adaptive immune responses to the human immunodeficiency virus (HIV), tuberculosis (TB), and influenza so that they can understand better ways to make preventive vaccines against these three infectious diseases. The NIH RePORTER goes into more detail about the project receiving $13.8 million in NIH life science research funding:
Duke University’s Duke Forward program, a five-year, $3.25 billion fundraising campaign, has been going well this past year. Between July 1, 2012 and June 30, 2013, Duke University received $410.9 million in philanthropic contributions. According to a Duke University news article, this is the highest annual donations total in the university’s history.
Researchers at the University of North Carolina at Chapel Hill recently received a $3.5 million NIH award for their study “Gene Expression Patterns in Human Tumors Identified Using Transcript Sequencing.” The study is being led by Charles Perou, PhD. According to the University of North Carolina at Chapel Hill website, Dr. Perou is a distinguished professor of genomics at the university whose research interests include characterizing the biological diversity of human tumors using genomics, molecular genetics and cell biology.